Unknown

Dataset Information

Efficacy of Intralesional Botulinum Toxin A for Treatment of Painful Cutaneous Leiomyomas: A Randomized Clinical Trial.


ABSTRACT:

Importance

Cutaneous leiomyomas can be associated with severe paroxysmal pain in which nerve conduction may have a key role. Medical management of painful cutaneous leiomyomas is generally unsatisfactory.

Objective

To assess the efficacy of intralesional botulinum toxin A in the management of pain associated with cutaneous leiomyomas.

Design, setting, and participants

Randomized, double-blind, placebo-controlled pilot study conducted from January 5, 2009, to March 27, 2014. The setting was a single-center study at the National Institutes of Health among participants 18 years or older with cutaneous leiomyomas characterized by pain at least once weekly and pain of at least 4 on a pain scale ranging from 0 to 10.

Interventions

Eighteen participants were randomize

SUBMITTER: Naik HB 

PROVIDER: S-EPMC7712636 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature